Shanghai Shen Lian Biomedical Corp Class A 688098
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥4.23
- Day Range
- ¥4.30–4.95
- 52-Week Range
- ¥3.63–8.13
- Bid/Ask
- ¥4.86 / ¥4.87
- Market Cap
- ¥2.00 Bil
- Volume/Avg
- 8.1 Mil / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.76
- Dividend Yield (Trailing)
- 0.72%
- Dividend Yield (Forward)
- 0.72%
- Total Yield
- 0.72%
Company Profile
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 380
- Website
- http://www.slbio.com.cn
Comparables
Valuation
|
Metric
|
688098
|
688197
|
301207
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 17.92 |
Price/Book Value | 1.39 | 6.22 | 2.11 |
Price/Sales | 5.76 | 1,419.80 | 5.45 |
Price/Cash Flow | 38.49 | — | 13.22 |
Price/Earnings
688098
688197
301207
Financial Strength
|
Metric
|
688098
|
688197
|
301207
|
|---|---|---|---|
Quick Ratio | 5.14 | 5.01 | 2.85 |
Current Ratio | 6.45 | 7.48 | 3.42 |
Interest Coverage | — | −1,925.03 | 149.96 |
Quick Ratio
688098
688197
301207
Profitability
|
Metric
|
688098
|
688197
|
301207
|
|---|---|---|---|
Return on Assets (Normalized) | −0.90% | −19.22% | 9.24% |
Return on Equity (Normalized) | −0.96% | −21.07% | 11.52% |
Return on Invested Capital (Normalized) | −1.00% | −22.11% | 10.82% |
Return on Assets
688098
688197
301207
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Lvmhfzxxs | Fwnh | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Nwzmypm | Dmbgbkz | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Tbtsprzy | Nvjqf | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Svlmgyqn | Vbskvc | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Zggxwhbc | Stg | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Wvspkkf | Tmyyw | $28.1 Bil | |||
| Moderna Inc
MRNA
| Hbbgsgrq | Spyp | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Vmmpyll | Tzxln | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Mcljsfm | Ggnnx | $13.4 Bil | |||
| Incyte Corp
INCY
| Vkxvynzbl | Gpdmvtr | $12.7 Bil |
United States